Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors

Hugo R. Arias, Dominik Feuerbach, Katarzyna M. Targowska-Duda, Megan Russell, Krzysztof Jozwiak

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

We compared the interaction of fluoxetine and paroxetine, two selective serotonin reuptake inhibitors (SSRIs), with the human (h) α4β2, R3beta;4, and R7 nicotinic acetylcholine receptors (AChRs) in different conformational states, using Ca2+ influx, radioligand binding, and molecular docking approaches. The results established that (1) fluoxetine was more potent than paroxetine in inhibiting agonist-activated Ca2+ influx on hR4β2 and αh7 AChRs, whereas the potency of both SSRIs was practically the same in the hα3β4 AChR. However, paroxetine was more potent in the hR7 AChR. (2) SSRIs bind to the [3H]imipramine locus with higher affinity when theAChRs are in the desensitized states compared to the resting states. (3) The different receptor specificity for fluoxetine determined by their inhibitory potencies or binding affinities suggests different modes of interaction when the AChR is in the closed or activated state. (4) Neutral and protonated fluoxetine interacts with a binding domain located in the middle of the AChR ion channel. In conclusion, SSRIs inhibit the most important neuronal AChRs with potencies and affinities that are clinically relevant by binding to a luminal site that is shared with tricyclic antidepressants.

Original languageEnglish
Pages (from-to)5734-5742
Number of pages9
JournalBiochemistry
Volume49
Issue number27
DOIs
StatePublished - 13 Jul 2010
Externally publishedYes

Fingerprint

Serotonin Uptake Inhibitors
Nicotinic Receptors
Cholinergic Receptors
Fluoxetine
Paroxetine
Imipramine
Tricyclic Antidepressive Agents
Ion Channels

Cite this

Arias, Hugo R. ; Feuerbach, Dominik ; Targowska-Duda, Katarzyna M. ; Russell, Megan ; Jozwiak, Krzysztof. / Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors. In: Biochemistry. 2010 ; Vol. 49, No. 27. pp. 5734-5742.
@article{7c0a9535c6ea4b69a8a29373063440d8,
title = "Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors",
abstract = "We compared the interaction of fluoxetine and paroxetine, two selective serotonin reuptake inhibitors (SSRIs), with the human (h) α4β2, R3beta;4, and R7 nicotinic acetylcholine receptors (AChRs) in different conformational states, using Ca2+ influx, radioligand binding, and molecular docking approaches. The results established that (1) fluoxetine was more potent than paroxetine in inhibiting agonist-activated Ca2+ influx on hR4β2 and αh7 AChRs, whereas the potency of both SSRIs was practically the same in the hα3β4 AChR. However, paroxetine was more potent in the hR7 AChR. (2) SSRIs bind to the [3H]imipramine locus with higher affinity when theAChRs are in the desensitized states compared to the resting states. (3) The different receptor specificity for fluoxetine determined by their inhibitory potencies or binding affinities suggests different modes of interaction when the AChR is in the closed or activated state. (4) Neutral and protonated fluoxetine interacts with a binding domain located in the middle of the AChR ion channel. In conclusion, SSRIs inhibit the most important neuronal AChRs with potencies and affinities that are clinically relevant by binding to a luminal site that is shared with tricyclic antidepressants.",
author = "Arias, {Hugo R.} and Dominik Feuerbach and Targowska-Duda, {Katarzyna M.} and Megan Russell and Krzysztof Jozwiak",
year = "2010",
month = "7",
day = "13",
doi = "10.1021/bi100536t",
language = "English",
volume = "49",
pages = "5734--5742",
journal = "Biochemistry",
issn = "0006-2960",
number = "27",

}

Arias, HR, Feuerbach, D, Targowska-Duda, KM, Russell, M & Jozwiak, K 2010, 'Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors', Biochemistry, vol. 49, no. 27, pp. 5734-5742. https://doi.org/10.1021/bi100536t

Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors. / Arias, Hugo R.; Feuerbach, Dominik; Targowska-Duda, Katarzyna M.; Russell, Megan; Jozwiak, Krzysztof.

In: Biochemistry, Vol. 49, No. 27, 13.07.2010, p. 5734-5742.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors

AU - Arias, Hugo R.

AU - Feuerbach, Dominik

AU - Targowska-Duda, Katarzyna M.

AU - Russell, Megan

AU - Jozwiak, Krzysztof

PY - 2010/7/13

Y1 - 2010/7/13

N2 - We compared the interaction of fluoxetine and paroxetine, two selective serotonin reuptake inhibitors (SSRIs), with the human (h) α4β2, R3beta;4, and R7 nicotinic acetylcholine receptors (AChRs) in different conformational states, using Ca2+ influx, radioligand binding, and molecular docking approaches. The results established that (1) fluoxetine was more potent than paroxetine in inhibiting agonist-activated Ca2+ influx on hR4β2 and αh7 AChRs, whereas the potency of both SSRIs was practically the same in the hα3β4 AChR. However, paroxetine was more potent in the hR7 AChR. (2) SSRIs bind to the [3H]imipramine locus with higher affinity when theAChRs are in the desensitized states compared to the resting states. (3) The different receptor specificity for fluoxetine determined by their inhibitory potencies or binding affinities suggests different modes of interaction when the AChR is in the closed or activated state. (4) Neutral and protonated fluoxetine interacts with a binding domain located in the middle of the AChR ion channel. In conclusion, SSRIs inhibit the most important neuronal AChRs with potencies and affinities that are clinically relevant by binding to a luminal site that is shared with tricyclic antidepressants.

AB - We compared the interaction of fluoxetine and paroxetine, two selective serotonin reuptake inhibitors (SSRIs), with the human (h) α4β2, R3beta;4, and R7 nicotinic acetylcholine receptors (AChRs) in different conformational states, using Ca2+ influx, radioligand binding, and molecular docking approaches. The results established that (1) fluoxetine was more potent than paroxetine in inhibiting agonist-activated Ca2+ influx on hR4β2 and αh7 AChRs, whereas the potency of both SSRIs was practically the same in the hα3β4 AChR. However, paroxetine was more potent in the hR7 AChR. (2) SSRIs bind to the [3H]imipramine locus with higher affinity when theAChRs are in the desensitized states compared to the resting states. (3) The different receptor specificity for fluoxetine determined by their inhibitory potencies or binding affinities suggests different modes of interaction when the AChR is in the closed or activated state. (4) Neutral and protonated fluoxetine interacts with a binding domain located in the middle of the AChR ion channel. In conclusion, SSRIs inhibit the most important neuronal AChRs with potencies and affinities that are clinically relevant by binding to a luminal site that is shared with tricyclic antidepressants.

UR - http://www.scopus.com/inward/record.url?scp=77954753254&partnerID=8YFLogxK

U2 - 10.1021/bi100536t

DO - 10.1021/bi100536t

M3 - Article

C2 - 20527991

AN - SCOPUS:77954753254

VL - 49

SP - 5734

EP - 5742

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 27

ER -